Clinical Trials Related to Dana-Farber Cancer Institute

Related studies linked through entity extraction aliases.

Eribulin in HER2 Negative Metastatic BrCa

Status: COMPLETED
Phase: PHASE2

NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer

Status: COMPLETED
Phase: PHASE1

Melatonin Versus Placebo in Breast Cancer

Status: COMPLETED
Phase: EARLY_PHASE1

Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)

Status: TERMINATED
Phase: NA

Clofarabine for Langerhans in Pedi

Status: WITHDRAWN
Phase: PHASE2

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

Status: COMPLETED
Phase: PHASE2

BKM120 For Triple Negative Breast Cancer

Status: COMPLETED
Phase: PHASE2

A Phase II Trial of Regadenoson in Sickle Cell Anemia

Status: COMPLETED
Phase: PHASE2

Serious Illness Communication Project

Status: COMPLETED
Phase: NA

Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer

Status: COMPLETED
Phase: PHASE1

Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors

Status: COMPLETED
Phase: PHASE2

GVAX vs. Placebo for MDS/AML After Allo HSCT

Status: TERMINATED
Phase: PHASE2

Ponatinib for Squamous Cell Lung and Head and Neck Cancers

Status: TERMINATED
Phase: PHASE2/PHASE3

Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant

Status: COMPLETED
Phase: PHASE2

INHERIT EGFR - Studying Germline EGFR Mutations

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

Dendritic Cell Activating Scaffold in Melanoma

Status: COMPLETED
Phase: PHASE1

FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer

Status: COMPLETED
Phase: PHASE2

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

Status: TERMINATED
Phase: PHASE2

BKM120+Abiraterone Acetate for Metastatic CRPC

Status: TERMINATED
Phase: PHASE1

Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches

Status: COMPLETED
Phase: NA